66.67
+0.36
(0.54%)
Real-time:
12:12PM EDT
NYSE
real-time data -
Disclaimer
Currency in USD
| Range | 66.15 - 66.74 |
| 52 week | 46.29 - 66.88 |
| Open | 66.43 |
| Vol / Avg. | 1.68M/7.65M |
| Mkt cap | 104.90B |
| P/E | 21.60 |
| Div/yield | 0.51/3.06 |
| EPS | 3.09 |
| Shares | 1.57B |
| Beta | 0.32 |
| Inst. own | 67% |
Events
Jul 18, 2012
Q2 2012 Abbott Earnings Conference Call -
Jun 6, 2012
Abbott at Goldman Sachs Healthcare Conference -
May 8, 2012
Abbott at Deutsche Bank AG Health Care Conference -
|
More events from DailyFinance »
|
Key stats and ratios
| Q2 (Jun '12) | 2011 | |
| Net profit margin | 17.59% | 12.17% |
| Operating margin | 21.45% | 14.81% |
| EBITD margin | - | 22.64% |
| Return on average assets | - | 7.83% |
| Return on average equity | - | 20.07% |
| Employees | 91,000 | - |
| Carbon Disclosure Rating | - | 72/100 |
Address
100 Abbott Park Road
ABBOTT PARK, IL 60064
United States - Map
+1-847-9376100 (Phone)
+1-847-9371511 (Fax)
ABBOTT PARK, IL 60064
United States - Map
+1-847-9376100 (Phone)
+1-847-9371511 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
About Company - Wikipedia
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products. Abbott operates in five segments: Proprietary Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. In March 2012, STARLIMS Technologies, an Abbott company, acquired STARLIMS's French distributor Varilab; operations of two privately held Spanish businesses, operating as STARLIMS Iberica; a Dutch company, operating as STARLIMS Netherlands, with a branch office in Solna, Sweden; and the business of its Israeli distribution partner, STARLIMS Israel, Ltd. In addition, the Company established STARLIMS Germany GmbH, with offices in Witten, Germany.
Officers and directors
| Miles D. White | Chairman of the Board, Chief Executive Officer | |
| Thomas C. Freyman | Chief Financial Officer, Executive Vice President - Finance | |
| Laura J. Schumacher | Executive Vice President, General Counsel, Secretary | |
| Richard W. Ashley | Executive Vice President - Corporate Development | |
| Brian J. Blaser | Executive Vice President - Diagnostic Products | |
| John M. Capek Ph.D. | Executive Vice President - Medical Devices | |
| Richard A. Gonzalez | Executive Vice President - Pharmaceutical Products Group | |
| John C. Landgraf | Executive Vice President - Nutritional Products | |
| Stephen R. Fussell | Senior Vice President - Human Resources | |
| Carlos Alban | Senior Vice President - Proprietary Pharmaceutical Products, Global Commercial Operations |